BridgeBio Total Assets from 2010 to 2025

Stocks . USA . 
Stock . BridgeBio Oncology Therapeutics,
BBOT Stock   12.38  0.25  1.98%   
BridgeBio Oncology Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
194.4 M
Current Value
204.1 M
Quarterly Volatility
68 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BridgeBio Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BridgeBio Oncology's main balance sheet or income statement drivers, such as Selling General Administrative of 555.2 K, Other Operating Expenses of 613.6 K or EBITDA of 8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.97. BridgeBio financial statements analysis is a perfect complement when working with BridgeBio Oncology Valuation or Volatility modules.
  
Build AI portfolio with BridgeBio Stock
Check out the analysis of BridgeBio Oncology Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BridgeBio Stock Analysis

When running BridgeBio Oncology's price analysis, check to measure BridgeBio Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BridgeBio Oncology is operating at the current time. Most of BridgeBio Oncology's value examination focuses on studying past and present price action to predict the probability of BridgeBio Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BridgeBio Oncology's price. Additionally, you may evaluate how the addition of BridgeBio Oncology to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY